Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > LATEST
LATEST
-
REGULATORY DPP Calls for End to Off-Year Drug Price Cuts, Chuikyo Reform
June 15, 2026
-
BUSINESS Shionogi Invests in Reproductive Medicine Startup Dioseve
June 15, 2026
-
BUSINESS Chugai Files Tecentriq for Esophageal Cancer
June 15, 2026
-
BUSINESS AbbVie Japan Files Rinvoq for Takayasu Arteritis
June 15, 2026
-
ORGANIZATION LLP Extra Patient Charge Influences Generic Adoption at Over 40% of Hospitals: FPMAJ
June 15, 2026
-
BUSINESS Viatris Recalls Teicoplanin Generic over Shipment Testing Deviation
June 15, 2026
-
REGULATORY Pharma Wages Multi-Front Lobbying amid Push for Leaner Honebuto
June 12, 2026
-
REGULATORY Many Approved AGs Remain Unlisted Despite Final Pre-Reform Opportunity
June 12, 2026
-
REGULATORY iPark CEO Calls for National AI Drug Discovery Platform at LDP Hearing
June 12, 2026
-
REGULATORY MHLW Official Urges Proper IRB Selection under New GCP Rules
June 12, 2026
-
REGULATORY MHLW Panel Weighs Single IRB, DCT Metrics in Core Hospital Overhaul
June 12, 2026
-
BUSINESS Kyorin Starts Pivotal Study of Chronic Cough DTx in Japan
June 12, 2026
-
BUSINESS Lotte Biopharma CVC Invests in Swiss ADC Startup
June 12, 2026
-
BUSINESS Ono Seeks Velexbru Nod for CNS Involvement of Malignant Lymphoma
June 12, 2026
-
BUSINESS Ono Files Opdivo for Anaplastic Thyroid Cancer
June 12, 2026
-
REGULATORY Revolade, Bilanoa See First Generics in June Listing; 3 Final AGs on Roster
June 11, 2026
-
REGULATORY Official Hints at Potential Change to Growth Target in Draft Roadmap
June 11, 2026
-
BUSINESS Lilly Warns Against Off-Label Use of Mounjaro
June 11, 2026
-
BUSINESS BMS Seeks Japan Approval for Mezigdomide in Multiple Myeloma
June 11, 2026
-
BUSINESS SanBio Sees Akuugo Expanding to 20-30 Treatment Centers
June 11, 2026
ページ
Japan is opening a new chapter in sleep medicine. The recent decision to allow medical institutions to advertise “sleep disorders”…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…